“Oral lipid formulation type IV as an approach in the formulation of solid dosage forms with poorly soluble substances: Chremophor®RH 40 as a surfactant phase” (2021) Progress in Nutrition, 23(3), p. e2021279. doi:10.23751/pn.v23i3.12071.